A study into the impact of severe covid-19 infection on patients who receive stem cell transplants for blood cancers and blood disorders. Read more
We are delighted to announce that on 1 November Leuka and Leukaemia UK merged Read more
We are proud to be at the forefront of funding innovative research into gene therapy treatments Read more
A deal has been struck to let the NHS offer children an expensive new cancer therapy that has been called the most exciting treatment advance for decades Read more
Dr Konstantinos Tzelepis was awarded a Leukaemia UK research fellowship in 2020 and has developed a new class of cancer drug with the potential to treat leukaemia. Read more
The trustees of Leukaemia UK are delighted to announce that they have appointed Fiona Hazell as CEO of Leukaemia UK. Fiona brings a strong track record in not-for-profit leadership, starting her role on 9th September 2020. Read more
After eight successful years with us, Angela Smith-Morgan will be stepping down from her role as Co CEO of Leukaemia UK on 3rd September. Read more
At Leukaemia UK, we remain committed to funding crucial research into leukaemia and other blood cancers, even during this unprecedented time which is affecting so many aspects of our lives Read more
Leukaemia UK, like so many charities across the UK, has been hugely impacted by the cancellation of thousands of fundraising events due to COVID-19. Join this new campaign to help to raise vital funds for our cause. Read more
We understand that people affected by leukaemia or other blood cancers may have questions and queries about coronavirus (COVID-19) Read more
A unit funded by Leukaemia UK which allows people with blood cancer to have stem cell transplants as out-patients has been officially opened by its first patient, Nick Boles MP Read more
Discover our exciting events calendar Read more